International Conference on "eLearning for Human Capability Development" to Commence Tomorrow    Deputy Finance Minister for International Affairs Participates in Finance Deputies in Arab Countries 7th Meeting    Advanced Electronics Company to Participate in IKTVA 2022 Forum and Exhibition    Ministry of Health Reports 4,535 New COVID-19 Cases, 5,072 Recoveries in Saudi Arabia    Magnitude 5.8 Earthquake Strikes Chinese Province of Qinghai    Egypt Records 1569 New Cases of COVID-19    Weather Forecast for Sunday    Custodian of the Two Holy Mosques Condoles Brazilian President on Death of his Mother    New Zealand to Impose Restrictions After Omicron Community Spread    French President Makes Phone Call to Tunisian Counterpart    Saudi Handball Team Loses to Qatar in Main Round of 2022 Asian Men's Handball Championship    Al-Zamil: Forum represents great importance in enhancing KSA's industrial position    UAE stops drone flying operations    From Milan to Glasgow, young Moroccans commit to fighting climate change    Kingdom chairs meeting of aviation security experts group    Eighth Season of ABB FIA Formula E World Championship to kick off in Diriyah    Bocelli performs in AlUla in third Winter at Tantora    Women's presence in Saudi cybersecurity sector reaches 45%    RCU launches first autonomous electric pod in AlUla    Recoveries keep pace with new COVID-19 cases in KSA as numbers stay below 5,000–mark    Pope Francis pledges justice for abuse victims after report faults Benedict XVI    Saudi Arabia arrests 13,780 illegals in a week    3.5 million students return to in-person classes on Sunday    700 women footballers vie for a place in first-ever national team Jeddah hosts Green Ladies' first training camp    Six-time champion Al-Attiyah heads impressive field for Oman Rally Czech duo of Petr Kačirek and Václav Kopáček make first Oman appearance    Brazil to stop unvaccinated footballers playing in top leagues    Al-Jadaan: Flexible and measured approach in green, sustainable global economy is required    Houthi' allegations of Coalition targeted a detention center in Saada is incorrect: Brig. Gen. Al-Maliki The media reports marketed by Houthi militia reflects its usual misleading approach    20th Asian Handball Championship Main Round to Kick off Tomorrow    Yanbu Education wins two awards for distinguished academic performance in GCC    Tearful Adele postpones entire Las Vegas residency    'Bat Out Of Hell' singer Meat Loaf dies at 74    Mohammed Abdu honored in a unique, grandeur style Winning second Guinness certificate; Turki Al-Sheikh surprises him with presence on stage    Saudi Stock Exchange Main Index Ends Trading Higher at 12,290 Points    Riyadh's Qualitative Events Enrich its Winter, Attract World Attention    GASTAT: Real estate prices rise by 0.9% in Q4 of 2021    22 Drivers from 11 Countries to Race for Glory at 2022 Diriyah E-Prix from January 28, 2022    SFDA: Fat is a Source of Energy and Its Abundance is Linked to Chronic Diseases    Reflections on celebration of Christmas    Royal Commission for AlUla to Hold Custodian of the Two Holy Mosques Endurance Cup 2022, Richard Mille AlUla Desert Polo    Saudi Arabia's Pavilion at Expo 2020 Dubai Organizes a Dance Theatrical Show for Children    Saudi Arabia rebuffs UN resolution on 'sexual orientation'    Kabir Khan eyes on joint Indian – Saudi film projects    Bollywood superstar Salman Khan to dazzle Riyadh Season on Dec. 10    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



FDA authorizes third coronavirus vaccine in US
Published in The Saudi Gazette on 28 - 02 - 2021

The US Food and Drug Administration (FDA) authorized Johnson & Johnson's COVID-19 vaccine Saturday. It is the first single dose COVID-19 vaccine available in the US, and is one that "checks nearly all the boxes."
The FDA announced in a statement that it has issued "an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
"The EUA allows the Janssen COVID-19 Vaccine to be distributed in the US for use in individuals 18 years of age and older," it added.
In this regard, Acting FDA Commissioner Janet Woodcock said "The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccines with the urgency called for during this pandemic, using the agency's rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization."
For his part, President Joe Biden said, "This is exciting news for all Americans, and an encouraging development in our efforts to bring an end to the crisis. We know that the more people get vaccinated, the faster we will overcome the virus, get back to our friends and loved ones, and get our economy back on track."
"I want to be clear: This fight is far from over," he warned. "As I have said many times, things are still likely to get worse again as new variants spread, and the current improvement could reverse. There is light at the end of the tunnel, but we cannot let our guard down now or assume that victory is inevitable. We must continue to remain vigilant, act fast and aggressively," he stressed.
The FDA had already approved vaccines developed by Pfizer-BioNTech and Moderna.
With more than 28.5 million confirmed COVID-19 cases and over 511,000 reported deaths in the US since the start of the pandemic, and while the demand for vaccine still far exceeds supply, these vaccines can't come soon enough.
"A third safe and effective vaccine is very welcome news," Andy Slavitt, the White House's senior for COVID Response, tweeted on Friday.
"We need a vaccine that can be quickly mass produced," Dr. Greg Poland, head of the Mayo Clinic's Vaccine Research Group, said Friday. "We'd want to see a reasonable duration of efficacy and protection.
The vaccine was tested in more than 44,000 people in the US, South Africa and Latin America. Globally, it was 66.1% effective against moderate to severe/critical COVID-19 at least four weeks after vaccination, according to an FDA analysis. In the US, it is considered 72% effective, and offered 86% protection against severe forms of the disease.
"One dose will keep you out of the hospital, keep you out of the intensive care unit, and keep you out of the morgue," Dr. Paul Offit, a vaccine adviser to the FDA, told CNN's Wolf Blitzer on Friday. The vaccine comes with few side effects, most of which are mild, including pain at the injection site, headache, fatigue and muscle pain.
Overall, non-fatal serious adverse events were infrequent, according to the FDA's analysis, and there were no reported cases of anaphylaxis following vaccination in the trial. There have been a small number of severe allergic reactions with the Moderna and Pfizer/BioNTech vaccines.
More research is needed, but the FDA analysis also hinted that the J&J vaccine may help prevent asymptomatic infections. A January study from the CDC showed that most coronavirus cases are spread by people without symptoms. If a vaccine prevented asymptomatic infection, it might help reduce opportunities to transmit the disease — not just keep the vaccinated from getting sick.
With so much positive data, an independent group of advisers voted unanimously on Friday to recommend the emergency use authorization of the J&J vaccine. — Agencies


Clic here to read the story from its source.